BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17990950)

  • 1. Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?
    Rossi GP; Seccia TM; Pessina AC
    Clin Chem Lab Med; 2007; 45(12):1645-51. PubMed ID: 17990950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives.
    Cesari M; Zanchetta M; Burlina A; Pedon L; Maiolino G; Sticchi D; Pessina AC; Rossi GP
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):115-21. PubMed ID: 15528477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
    Pizzolo F; Friso S; Olivieri O; Martinelli N; Bozzini C; Guarini P; Trabetti E; Faccini G; Corrocher R; Girelli D
    Eur J Clin Invest; 2006 Oct; 36(10):698-704. PubMed ID: 16968465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients.
    Bokhari SW; Bokhari ZW; Zell JA; Lee DW; Faxon DP
    Coron Artery Dis; 2005 May; 16(3):153-61. PubMed ID: 15818084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In patients with coronary artery disease and left ventricular contractile insufficiency the pathogenicity of smoking associates with imbalance in metabolism of homocysteine].
    Strauss E; Supiński W; Głuszek J; Pawlak AL
    Przegl Lek; 2006; 63(10):951-6. PubMed ID: 17288192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of elevated plasma total homocysteine concentration on coronary atherosclerosis in Chinese patients with acute myocardial infarction undergoing primary coronary intervention.
    Chua S; Wu CJ; Chang HW; Hang CL; Chen CJ; Yang CH; Yip HK
    Int Heart J; 2005 Mar; 46(2):181-93. PubMed ID: 15876802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.
    Genest J; Frohlich J; Steiner G
    Am J Cardiol; 2004 Apr; 93(7):848-53. PubMed ID: 15050487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
    Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
    Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
    Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring subclinical atherosclerosis: is homocysteine relevant?
    Sarwar AB; Sarwar A; Rosen BD; Nasir K
    Clin Chem Lab Med; 2007; 45(12):1667-77. PubMed ID: 17990951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.
    van Meurs JB; Pare G; Schwartz SM; Hazra A; Tanaka T; Vermeulen SH; Cotlarciuc I; Yuan X; Mälarstig A; Bandinelli S; Bis JC; Blom H; Brown MJ; Chen C; Chen YD; Clarke RJ; Dehghan A; Erdmann J; Ferrucci L; Hamsten A; Hofman A; Hunter DJ; Goel A; Johnson AD; Kathiresan S; Kampman E; Kiel DP; Kiemeney LA; Chambers JC; Kraft P; Lindemans J; McKnight B; Nelson CP; O'Donnell CJ; Psaty BM; Ridker PM; Rivadeneira F; Rose LM; Seedorf U; Siscovick DS; Schunkert H; Selhub J; Ueland PM; Vollenweider P; Waeber G; Waterworth DM; Watkins H; Witteman JC; den Heijer M; Jacques P; Uitterlinden AG; Kooner JS; Rader DJ; Reilly MP; Mooser V; Chasman DI; Samani NJ; Ahmadi KR
    Am J Clin Nutr; 2013 Sep; 98(3):668-76. PubMed ID: 23824729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease.
    Bowron A; Scott J; Stansbie D
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):459-62. PubMed ID: 16259797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease.
    Lin YH; Pao KY; Yang WS; Wu VC; Chen YJ; Lin YL; Tsai WS; Tsai IJ; Gau CS; Hwang JJ
    Clin Chem Lab Med; 2008; 46(1):125-30. PubMed ID: 18194083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma leptin, homocysteine and nitric oxide levels with the presence and unstability of coronary artery disease.
    Basati G; Razavi AE; Abdi S; Sarrafzedegan N
    Biomark Med; 2014; 8(3):405-12. PubMed ID: 24712432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study.
    Chai HT; Chen YL; Chung SY; Tsai TH; Yang CH; Chen HC; Sung PH; Sun CK; Chang LT; Fan CQ; Yip HK
    Int Heart J; 2011; 52(5):280-5. PubMed ID: 22008436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Mehri S; Attia N; Ben Farhat M; Hammami M
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):515-21. PubMed ID: 20530057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease.
    Gupta M; Sharma P; Garg G; Kaur K; Bedi GK; Vij A
    Clin Chim Acta; 2005 Feb; 352(1-2):121-5. PubMed ID: 15653106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.